DSIP (Delta Sleep-Inducing Peptide)

What the Antibody Found in Peripheral Tissue

UKPWritten and published by UK Peptides2 min readUpdated 2 cited sources

The short answer

Graf and Kastin reported DSIP-like material across 12 rat tissue areas by radioimmunoassay, ranging from 86 pg/mg in muscle to 849 pg/mg in stomach. Chromatography then showed the immunoreactive material was mostly larger than DSIP itself.

Key facts

Study
Graf & Kastin 1984 (PMID 6548030)
Journal
Proc Soc Exp Biol Med, October 1984
Tissues examined
12 areas
Lowest
86 pg/mg (muscle)
Highest
849 pg/mg (stomach)
Chromatography result
Material mostly larger than DSIP
After trypsin
Small immunoreactive peptides appeared

What the study set out to do

DSIP had been reported in brain by radioimmunoassay and immunocytochemistry. Graf and Kastin extended the measurement to peripheral tissue, extracting 12 areas with water and quantifying immunoreactive material in each. Asking whether a supposedly brain-associated peptide appears elsewhere is a reasonable and useful question.

The distribution they found

Immunoreactive material in every area, from 86 pg/mg in muscle to 849 pg/mg in stomach, roughly a tenfold range, with the highest reading in the gastrointestinal tract. For a peptide named after an effect on sleep, the stomach being the richest source is not what the name would lead anyone to expect.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

The chromatography, which is the important part

They ran the material on Sephadex G-15 and G-25 columns, which separate by size. The immunoreactive material appeared mostly larger than DSIP. So whatever the antibody was binding in these tissues was predominantly not the nine-residue peptide. It was bigger molecules carrying a region the antibody recognised.

What the trypsin experiment adds

Digesting the material with trypsin produced small immunoreactive peptides with only minimal reduction in immunoreactivity. That is consistent with the epitope being contained inside larger molecules and released by cleavage, which is a coherent explanation, and also means the original signal was not measuring free peptide.

Why the title says what it says

The paper is titled DSIP-like material exists in peripheral organs of rats in large dissociable forms. Every element of that is doing work: DSIP-like rather than DSIP, material rather than peptide, and large dissociable forms describing what was actually found. The authors reported the complication rather than burying it.

How this bears on the wider literature

Distribution data is often cited as evidence that an endogenous peptide is real and functionally placed. Where that data comes from immunoassay and the immunoreactive material turns out to be mostly something larger, the inference weakens considerably. This is one reason a fifty-year literature has not consolidated, and it was visible in the primary work from the beginning.

Quick reference

ObservationWhat it shows
Immunoreactivity in 12 tissuesThe antibody bound something everywhere
Highest in stomach, 849 pg/mgNot a brain-restricted distribution
Mostly larger by chromatographyMost of it was not DSIP
Trypsin releases small fragmentsEpitope sits inside larger molecules

Frequently asked questions

Where was DSIP-like material most abundant?

Stomach, at 849 pg/mg, against a low of 86 pg/mg in muscle across the 12 areas examined.

Was it actually DSIP?

Chromatography showed the immunoreactive material was mostly larger than DSIP, so predominantly not the nine-residue peptide.

What did trypsin digestion show?

It produced small immunoreactive peptides with minimal loss of immunoreactivity. Consistent with the epitope sitting inside larger molecules.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.